View Author
abciximab st-segment elevation intracoronary infarction administration percutaneou intervention circulation abciximab administration thrombus aspiration elevation center st-segment patient van der horst center groningen university emergency reperfusion bolus abciximab application groningen van den heuvel heart study aspiration trial article permission wohrle j heuvel zijlstra f erasmus mc phd department intracoronary administration information groningen groningen zijlstra horst randomized point schuler g randomized studies reperfusion thrombu heart j university infarct-related artery youlan l copyright clearance center resonance letter bsc hans l phd bart j.g.l application phd gabija pundziute fokkema intracoronary abciximab infusion netherland siyrous hoseyni guyomi erasmu service kampinga wieringa md wouter g phd thoraxcenter erasmus american netherlands felix zijlstra intervention abciximab iv comparison guyomi pundziute phd ad f.m click request permissions md iwan c.c felix zijlstra circulation prespecified end point resonance 2 days hillege cicero md marieke l american heart association association
1 Most Recent Publications
|
Response to letter regarding article, "intracoronary versus intravenous administration of abciximab in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: The comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of st-segment elevation myocardial infarction
(Article)
Gu, Y.L. Kampinga, M.A. Horst, I.C.C. van der Smet, B.J.G.L. de Nijsten, M.W. Zijlstra, F.J. Wieringa, W.G. Fokkema, M.L. Hillege, H.L. Heuvel, A.F.M. van den Tan, E.-S. Pundziute, G. Werf, R. van der Guyomi, S.H. |
2011-08-23
|